MyFinsight
Home
Blog
About
Contact
Download
Download image
Net change in cash,
cash equivalents and...
-$19,660K
Contract liabilities
$10,402K
Stock-based compensation
$2,196K
Depreciation and
amortization
$1,763K
Non-cash operating lease
expense
$654K
Other noncurrent
assets
-$461K
Other
-$8K
Net cash used in
operating activities
-$19,234K
Net cash (used)
provided by financing...
-$415K
Net cash (used)
provided by investing...
-$11K
Canceled cashflow
$15,484K
Net loss
-$19,272K
Payment of accrued
offering costs
$415K
Purchases of property and
equipment
$11K
Accounts receivable
$10,627K
Accrued and other
current liabilities
-$2,637K
Accounts payable
-$1,460K
Operating lease
liabilities
-$713K
Prepaid expenses and
other current assets
$9K
Back
Back
Cash Flow
source: myfinsight.com
Tenaya Therapeutics, Inc. (TNYA)
Tenaya Therapeutics, Inc. (TNYA)